[Results of combined therapy for brain tumors of various origin].
Treatment and prognosis of neurooncolical patients are largely determined whether tumor is a primary brain neoplasm or metastasis. Out of 284 brain cancer patients treated at the Institute's Clinic, 262 had primary tumors and 22--metastases from various sites. Combined therapy was given to 273: surgery--241, radiotherapy--273 and polychemotherapy--263. Three-year survival was reported in patients with anaplastic astrocytoma stage II (90%), stage III--(51%) and stage IV--(14%). Eighty percent of cases of brain metastases have been followed up for 9 months.
Korytova
L I
LI
Central Research Institute of Roentgeno-Radiology, Ministry of Health of the RF, St. Petersburg.
Zhabina
P M
PM
Khazova
T V
TV
Sokurenko
V P
VP
Gopta
E V
EV
Busina
E Iu
EIu
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001254:Astrocytoma / Q000473:pathology / Q000628:therapy; D001932:Brain Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy / Q000556:secondary / Q000601:surgery / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D006801:Humans; D009367:Neoplasm Staging; D018714:Radiotherapy, Adjuvant; D016896:Treatment Outcome